World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
47
Citations
8231
World Ranking
4532
National Ranking
214

Jean-Luc Taupin publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jean-Luc Taupin sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 217 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jean-Luc Taupin D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jean-Luc Taupin sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 47 D-Index — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jean-Luc Taupin is affiliated with Université Paris Cité in France and has a significant body of work in the fields of Medicine and Immunology and Microbiology. Their research primarily addresses topics related to immunology, transplantation, and surgery.

The scientist's published work spans multiple topics, including:

  • Renal Transplantation Outcomes and Treatments
  • T-cell and B-cell Immunology
  • Transplantation: Methods and Outcomes
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • Organ Transplantation Techniques and Outcomes
  • Polyomavirus and related diseases

Jean-Luc Taupin has recent notable papers published in respected journals. These include:

  • Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation, 2020, Circulation
  • Clinical recommendations for posttransplant assessment of anti-HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document, 2023, American Journal of Transplantation
  • Transient mTOR inhibition rescues 4-1BB CAR-Tregs from tonic signal-induced dysfunction, 2021, Nature Communications
  • Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report, 2023, American Journal of Transplantation
  • The MHC class I MICA gene is a histocompatibility antigen in kidney transplantation, 2022, Nature Medicine

The frequent co-authors collaborating with Jean-Luc Taupin include:

  • Magali Devriese
  • Cédric Usureau
  • Maryvonnick Carmagnat
  • Sephora Da Silva
  • Romain Lhotte

In terms of publication venues, their research has appeared most often in the following journals and platforms:

  • HLA
  • American Journal of Transplantation
  • Transplant International
  • Clinical Transplantation
  • bioRxiv (Cold Spring Harbor Laboratory)

The researcher's work covers subfields such as Immunology, Transplantation, Surgery, Oncology, and Epidemiology. This breadth reflects a comprehensive approach to understanding immune responses, transplant outcomes, and associated medical treatments.

Best Publications

  • Enhancing Effect of IL-17 on IL-1-Induced IL-6 and Leukemia Inhibitory Factor Production by Rheumatoid Arthritis Synoviocytes and Its Regulation by Th2 Cytokines

    Martine Chabaud;François Fossiez;Jean-Luc Taupin;Pierre Miossec

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Decreased Expression of the Signal-transducing ζ Chains in Tumor-infiltrating T-Cells and NK Cells of Patients with Colorectal Carcinoma

    Hiroshi Nakagomi;Max Petersson;Inger Magnusson;Claes Juhlin

  • Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.

    Patrick Blanco;Vincent Pitard;Jean-François Viallard;Jean-Luc Taupin

  • Detection of C3d-Binding Donor-Specific Anti-HLA Antibodies at Diagnosis of Humoral Rejection Predicts Renal Graft Loss

    Antoine Sicard;Antoine Sicard;Stéphanie Ducreux;Maud Rabeyrin;Lionel Couzi

  • Concentration of leukaemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation.

    N. Lédée-Bataille;G. Laprée-Delage;J.-L. Taupin;S. Dubanchet

  • Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease.

    Masanori Matsuda;Max Petersson;Rodica Lenkei;Jean-Luc Taupin

  • Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group.

    Carrie A. Schinstock;Roslyn B. Mannon;Klemens Budde;Anita S. Chong

  • Non-Complement–Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival

    Gwendaline Guidicelli;Florent Guerville;Sébastien Lepreux;Chris Wiebe

  • The RNA-binding protein TIAR is translocated from the nucleus to the cytoplasm during Fas-mediated apoptotic cell death.

    Jean Luc Taupin;Qingsheng Tian;Nancy Kedersha;Michael Robertson

  • In-vitro endometrial secretion of human interleukin for DA cells/leukaemia inhibitory factor by explant cultures from fertile and infertile women.

    G. Delage;J.-F. Moreau;J.-L. Taupin;S. Freitas

  • Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants.

    Alice Koenig;Alice Koenig;Chien-Chia Chen;Antoine Marçais;Thomas Barba;Thomas Barba

  • CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells.

    J Déchanet;C Grosset;J L Taupin;P Merville

  • Major Expansion of γδ T Lymphocytes following Cytomegalovirus Infection in Kidney Allograft Recipients

    Julie Déchanet;Pierre Merville;Frank Bergé;Gabriel Bone-Mane

  • Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients

    Carmen Lefaucheur;Denis Viglietti;Yassine Bouatou;Aurélie Philippe

  • Deciphering complement interference in anti-human leukocyte antigen antibody detection with flow beads assays.

    Jonathan Visentin;Margaux Vigata;Sophie Daburon;Cécile Contin-Bordes

  • Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis

    Antoine Bouquegneau;Antoine Bouquegneau;Charlotte Loheac;Olivier Aubert;Olivier Aubert;Yassine Bouatou;Yassine Bouatou

  • Interpretation of positive flow cytometric crossmatch in the era of the single-antigen bead assay.

    Lionel Couzi;Caroline Araujo;Gwendaline Guidicelli;Thomas Bachelet

  • HLA-DR expression on lymphocyte subsets as a marker of disease activity in patients with systemic lupus erythematosus.

    J F Viallard;C Bloch-Michel;M Neau-Cransac;J L Taupin

  • Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens.

    Marianne Delville;Marianne Delville;Baptiste Lamarthée;Sylvain Pagie;Sarah S.B. See

  • Leukemia Inhibitory Factor: Part of a Large Ingathering Family

    Jean-Luc Taupin;Vincent Pitard;Julie Dechanet;Veronique Miossec

  • Kidney Intragraft Donor-Specific Antibodies as Determinant of Antibody-Mediated Lesions and Poor Graft Outcome

    T. Bachelet;L. Couzi;S. Lepreux;M. Legeret

  • The mannose 6-phosphate/insulin-like growth factor II receptor is a nanomolar affinity receptor for glycosylated human leukemia inhibitory factor.

    Frédéric Blanchard;Sylvie Raher;Laurence Duplomb;Patricia Vusio

  • Cutting Edge: Modulation of Fas-Mediated Apoptosis by Lipid Rafts in T Lymphocytes

    Patrick Legembre;Sophie Daburon;Patrick Moreau;Jean-François Moreau

  • Denatured class I human leukocyte antigen antibodies in sensitized kidney recipients: prevalence, relevance, and impact on organ allocation.

    Jonathan Visentin;Gwendaline Guidicelli;Thomas Bachelet;Christian Jacquelinet

Frequent Co-Authors

Jean-François Moreau
Jean-François Moreau University of Bordeaux
Gérard Chaouat
Gérard Chaouat Grenoble Alpes University
Yannick Jacques
Yannick Jacques University of Nantes
Nassim Kamar
Nassim Kamar Paul Sabatier University
Christophe Legendre
Christophe Legendre Necker-Enfants Malades Hospital
Patrick Blanco
Patrick Blanco University of Bordeaux
Marc Bonneville
Marc Bonneville Institut Mérieux (France)
Pascale Loiseau
Pascale Loiseau Hôpital Saint-Louis
Patrick Bruneval
Patrick Bruneval Grenoble Alpes University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their careers in immunology and healthcare, exploring related nursing degrees can be a strategic move. Programs like the fnp to acute care np bridge program offer a pathway for Family Nurse Practitioners to specialize further, gaining expertise applicable to clinical immunology settings.

Accelerated programs are particularly beneficial for professionals seeking fast-track options. The accelerated fnp programs enable nurses to earn advanced credentials while accommodating busy schedules, which is ideal for those looking to deepen their immunology knowledge swiftly.

For individuals from non-nursing backgrounds, 12-month accelerated nursing programs online for non nurses provide an accessible route into the nursing profession. These programs build foundational skills rapidly, creating opportunities to pivot toward specialized areas such as immunology research and patient care.

Similarly, 12-month accelerated nursing programs cater to those seeking efficient entry points into nursing careers. Completing such programs can be a crucial first step for pursuing advanced immunology-focused roles or graduate studies, opening doors to diverse healthcare pathways.

Best Scientists Citing Jean-Luc Taupin

Trending Scientists

Recently Published Articles